Trial NCT05120960

View at ClinicalTrials.gov 
Org. Study IDs: 2021-0281
Secondary IDs: NCI-2021-12845

Last trial update was posted on 2024-04-17

MeSH Interventions

Osimertinib Tepotinib

MeSH Conditions

Brain Neoplasms

Other Conditions

Brain Tumor

Stopping Reasons

0 participant accrual

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID